212 related articles for article (PubMed ID: 33909674)
41. Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea.
Park SY; Kim SH; Kim TY; Lee YK; Ha YC; Jang S; Ahn SH; Kim HY
J Korean Med Sci; 2021 Jul; 36(27):e186. PubMed ID: 34254473
[TBL] [Abstract][Full Text] [Related]
42. Incidence and Risk of Venous Thromboembolism in Patients With Resectable Pancreatic Cancer Receiving Neoadjuvant Chemotherapy.
Kamiya M; Kawahara S; Kamioka Y; Murakawa M; Aoyama T; Kobayashi S; Ueno M; Yamamoto N; Oshima T; Yukawa N; Rino Y; Masuda M; Morinaga S
Anticancer Res; 2023 Apr; 43(4):1741-1747. PubMed ID: 36974795
[TBL] [Abstract][Full Text] [Related]
43. Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study.
Huang H; Korn JR; Mallick R; Friedman M; Nichols C; Menzin J
J Thromb Thrombolysis; 2012 Nov; 34(4):446-56. PubMed ID: 22581282
[TBL] [Abstract][Full Text] [Related]
44. Incidence of venous thromboembolism in patients with ovarian cancer receiving neoadjuvant chemotherapy: systematic review and meta-analysis.
Black KA; Bowden S; Chu P; McClurg C; Pin S; Metcalfe A
Int J Gynecol Cancer; 2024 Jun; 34(6):855-862. PubMed ID: 38431288
[TBL] [Abstract][Full Text] [Related]
45. Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer.
Eurola A; Mustonen H; Mattila N; Lassila R; Haglund C; Seppänen H
Cancer Med; 2022 Apr; 11(7):1605-1616. PubMed ID: 35148464
[TBL] [Abstract][Full Text] [Related]
46. Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery.
Rollins KE; Peters CJ; Safranek PM; Ford H; Baglin TP; Hardwick RH
Eur J Surg Oncol; 2011 Dec; 37(12):1072-7. PubMed ID: 21925829
[TBL] [Abstract][Full Text] [Related]
47. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry.
Golemi I; Cote L; Iftikhar O; Brenner B; Tafur A; Bikdeli B; Fernández-Capitán C; Pedrajas JM; Otero R; Quintavalla R; Monreal M;
J Vasc Surg Venous Lymphat Disord; 2020 May; 8(3):353-359.e1. PubMed ID: 31784355
[TBL] [Abstract][Full Text] [Related]
48. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study.
Chung WS; Lin CL; Sung FC; Lu CC; Kao CH
Thromb Res; 2014 Sep; 134(3):622-6. PubMed ID: 25034321
[TBL] [Abstract][Full Text] [Related]
49. Retrospective Evaluation of Thromboembolism Risk in Ovarian Cancer Patients Treated with Bevacizumab.
Kuk A; Magnowska M; Suchy W; Swierczynska J; Zaborowski MP; Gaca M; Nowak-Markwitz E
Target Oncol; 2017 Aug; 12(4):495-503. PubMed ID: 28580507
[TBL] [Abstract][Full Text] [Related]
50. Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial.
Mandalà M; Barni S; Prins M; Labianca R; Tondini C; Russo L; Milesi A; Cremonesi M; Zaccanelli M; Regonesi C; Moro C; Falanga A
Ann Oncol; 2010 Apr; 21(4):871-876. PubMed ID: 19713246
[TBL] [Abstract][Full Text] [Related]
51. Predictive value of HDL cholesterol for cancer-associated venous thromboembolism during chemotherapy.
Ferroni P; Roselli M; Riondino S; Guadagni F
J Thromb Haemost; 2014 Dec; 12(12):2049-53. PubMed ID: 25256037
[TBL] [Abstract][Full Text] [Related]
52. Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from England.
Walker AJ; West J; Card TR; Humes DJ; Grainge MJ
J Thromb Haemost; 2014 May; 12(5):641-9. PubMed ID: 24977288
[TBL] [Abstract][Full Text] [Related]
53. Stratification of venous thromboembolism risk in ovarian cancer patients during chemotherapy.
Mereu L; Tateo S; Klersy C; Martinotti Gabellotti E; Polatti F
Int J Gynecol Cancer; 2009 Jan; 19(1):79-83. PubMed ID: 19258946
[TBL] [Abstract][Full Text] [Related]
54. Risk factors and treatment of venous thromboembolism in perioperative patients with ovarian cancer in China.
Zhang W; Liu X; Cheng H; Yang Z; Zhang G
Medicine (Baltimore); 2018 Aug; 97(31):e11754. PubMed ID: 30075594
[TBL] [Abstract][Full Text] [Related]
55. The occurrence of venous thromboembolism in cancer patients following major surgery.
Toledano TH; Kondal D; Kahn SR; Tagalakis V
Thromb Res; 2013 Jan; 131(1):e1-5. PubMed ID: 23174626
[TBL] [Abstract][Full Text] [Related]
56. Venous Thromboembolism in Children and Young Adults in Korea: Analysis of the Korean Health Insurance Review and Assessment Service Database.
Park ES; Choi HS; Lee KS; Kim SW; Lee JM
J Korean Med Sci; 2019 Dec; 34(49):e316. PubMed ID: 31858756
[TBL] [Abstract][Full Text] [Related]
57. Significance of venous thromboembolism in women with cervical cancer.
Matsuo K; Moeini A; Machida H; Fullerton ME; Shabalova A; Brunette LL; Roman LD
Gynecol Oncol; 2016 Sep; 142(3):405-12. PubMed ID: 27350404
[TBL] [Abstract][Full Text] [Related]
58. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
[TBL] [Abstract][Full Text] [Related]
59. Perioperative Incidence of Venous Thromboembolism in Patients With Ovarian Cancer Using Four Different Data Collection Methods: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study.
Smith S; Lambert P; Nachtigal MW; Altman AD
J Obstet Gynaecol Can; 2022 May; 44(5):475-481. PubMed ID: 34718149
[TBL] [Abstract][Full Text] [Related]
60. Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
Riedl JM; Posch F; Bezan A; Szkandera J; Smolle MA; Winder T; Rossmann CH; Schaberl-Moser R; Pichler M; Stotz M; Stöger H; Gerger A
BMC Cancer; 2017 Jun; 17(1):415. PubMed ID: 28619086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
